ISSN: 3048-6939
JANOLI International Journal of
Applied Engineering and Management ( JIJAEM )
Login/Register
For Reference
About Journal Aim and Scope Editorial Board Publication Ethics Indexing And Abstracting Peer Review Process About Journal Aim and Scope Editorial Board Publication Ethics Indexing And Abstracting Peer Review Process

Interaction Monitoring: A Secure Covid-19 Charting Framework Using the

Authors: S P Singh

Published: 2025-04-28 16:41:44.482

Download PDF

Abstract

Due to touch spread, the latest coronavirus outbreak (COVID-19) was spreading daily among people and was brought on by the virus called SARS-CoV-2. Managing epidemics requires the identification of infectious disorders like COVID-19 and the prevention of their spread. Finding or investigating other transferable people was a key step in determining and tracking their past relationships, which will help in the cautious dissociation of any individuals who may have been contaminated and enable spread. Smart devices, like smartwatches and smartphones, can be used to track down these prior interactions. By the use of digital watches and mobile device monitoring techniques, and developed a COVID-19 epidemic simulation to assess the quantity of people isolated and the efficacy of the action that needs to be taken. Our research paper's findings demonstrate that, to be precise and successful in combating the COVID-19 pandemic, tracking contact methods need to be used quickly, a significant portion of the general public has to utilize smart devices, and the gadgets used for connection monitoring need to be efficient. Because of all these strict requirements, contact tracking via smart devices was not very effective in containing the illness throughout the COVID-19 pandemic. But during this stage, intelligent machine-based tracking of connections might prove to be very helpful in identifying another stage in which a subset of the population will be more immune.

Keywords

SARS-COVID-2, COVID-19, Pandemic, Symptoms, Innovative Technological Solutions, and Interaction Detection.

References

  1. Heymann DL (2020) Data sharing and outbreaks: best practice exemplified. Lancet 395:469– 470. https://doi.org/10.1016/S0140-6736(20)30184-7
  2. Ye M, Ren Y, Lv T (2020) Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun 88:945–946. https://doi.org/10.1016/j.bbi.2020.04.017
  3. Filatov A, Sharma P, Hindi F, Espinosa PS (2020) Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 12: https://doi.org/10.7759/cureus.7352
  4. Bikdeli B, Madhavan MV, Jimenez D et al (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 75:2950–2973. https://doi.org/10.1016/j.jacc.2020.04.031
  5. Nickbakhsh S, Ho A, Marques DFP et al (2020) Epidemiology of seasonal coronaviruses: establishing the context for the emergence of coronavirus disease 2019. J Infect Dis 222:17– 25. https://doi.org/10.1093/infdis/jiaa185
  6. Liu X, Wang X-J (2020) Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. J Genet Genomics 47:119– 121. https://doi.org/10.1016/j.jgg.2020.02.001
  7. Chan JF-W, To KK-W, Chen H, Yuen K-Y (2015) Cross-species transmission and emergence of novel viruses from birds. Curr Opin Virol 10:63–69. https://doi.org/10.1016/j.coviro.2015.01.006
  8. . He J, Tao H, Yan Y et al (2020) Molecular mechanism of evolution and human infection with SARS-CoV-2. Viruses 12:428. https://doi.org/10.3390/v12040428
  9. Guan W, Ni Z, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032
  10. Yan R, Zhang Y, Li Y, et al (2020) Structural basis for the recognition of SARS-CoV-2 by fulllength human ACE2. Science (80- ) 367:1444–1448. https://doi.org/10.1126/science.abb2762
  11. Ji W, Wang W, Zhao X et al (2020) Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol 92:433–440. https://doi.org/10.1002/jmv.25682 Zumla A, Hui DS, Perlman S (2015) Middle East respiratory syndrome. Lancet 386:995– 1007. https://doi.org/10.1016/S0140-6736(15)60454-8
  12. Read R (2020) Flawed methods in “COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism.” https://doi.org/10.26434/chemrxiv.11938173
  13. Boccia S, Ricciardi W, Ioannidis JPA (2020) What other countries can learn from Italy during the COVID-19 pandemic. JAMA Intern Med 180:927. https://doi.org/10.1001/jamainternmed.2020.1447
  14. Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. https://doi.org/10.1056/nejmoa2001017
  15. Lu R, Zhao X, Li J et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565– 574. https://doi.org/10.1016/S0140-6736(20)30251-8
  16. Goh G, Dunker A, Foster J, Uversky V (2019) HIV vaccine mystery and viral shell disorder. Biomolecules 9:178. https://doi.org/10.3390/biom9050178
  17. Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
  18. Zhou P, Yang X Lou, Wang XG, et al (2020) Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. https://doi.org/10.1101/2020.01.22.914952
  19. He J, Tao H, Yan Y, et al (2020) Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV). bioRxiv 2020.02.17.952903. https://doi.org/10.1101/2020.02.17.952903
  20. Ding N, Zhao K, Lan Y et al (2017) Induction of atypical autophagy by porcine hemagglutinating encephalomyelitis virus contributes to viral replication. Front Cell Infect Microbiol 7:56. https://doi.org/10.3389/fcimb.2017.00056
  21. Segars J, Katler Q, McQueen DB et al (2020) Prior and novel coronaviruses, coronavirus disease 2019 (COVID-19), and human reproduction: what is known? Fertil Steril 113:1140– 1149. https://doi.org/10.1016/j.fertnstert.2020.04.025
  22. Xu X, Chen P, Wang J et al (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63:457– 460
  23. Farnoosh G, Alishiri G, Zijoud SRH, et al (2020) Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease (COVID-19) based on available evidence - a narrative review. J Mil Med 22:1–11
  24. Kearney JE (2020) Chloroquine as a potential treatment and prevention measure for the 2019 novel coronavirus: a review. J Chem Inf Model 53, 1689. https://doi.org/10.20944/preprints202003.0275.v1
  25. Li X, Geng M, Peng Y et al (2020) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10:102–108. https://doi.org/10.1016/j.jpha.2020.03.001
  26. Gundlapally J, Kumar A, Kashyap A, et al (2020) In search of novel coronavirus 19 therapeutic targets. HELIX 10:01–08. https://doi.org/10.29042/2020-10-2-01-08
  27. Du L, Tai W, Zhou Y, Jiang S (2016) Vaccines for the prevention against the threat of MERSCoV. Expert Rev Vaccines 15:1123–1134. https://doi.org/10.1586/14760584.2016.1167603
  28. Yang Y, Lu Q, Liu M, et al (2020) Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medrxiv. https://doi.org/10.1101/2020.02.10.20021675
  29. Ganji A, Farahani I, Khansarinejad B et al (2020) Increased expression of CD8 marker on T-cells in COVID-19 patients. Blood Cells, Mol Dis 83:102437. https://doi.org/10.1016/j.bcmd.2020.102437
  30. Wan S, Yi Q, Fan S, et al (2020) Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv 2020.02.10.20021832. https://doi.org/10.1101/2020.02.10.20021832
  31. Ghazavi A, Ganji A, Khaki M, Mosayebi G (2018) Existential philosophy of the immune system: defense or homeostasis? HBI_Journals 21:110–120
  32. Wan Y, Shang J, Sun S et al (2020) Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J Virol 94:e02015-e2019. https://doi.org/10.1128/JVI.02015-19
  33. Khaki M, Ghazavi A, Ghasami K, et al (2011) Evaluation of viral antibodies in Iranian multiple sclerosis patients. Neurosci J 16:224 LP – 228
  34. Sun J, He W-T, Wang L et al (2020) COVID-19: epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol Med 26:483–495. https://doi.org/10.1016/j.molmed.2020.02.008
  35. Woo PCY, Huang Y, Lau SKP, Yuen K-Y (2010) Coronavirus genomics and bioinformatics analysis Viruses 2:1804–1820
  36. Wilson ME, Chen LH (2020) Travellers give wings to novel coronavirus (2019-nCoV). J Travel Med 27: https://doi.org/10.1093/jtm/taaa015
  37. Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA 323:1239. https://doi.org/10.1001/jama.2020.2648
  38. Gralinski LE, Menachery VD (2020) Return of the coronavirus: 2019-nCoV. Viruses 12:135
Download PDF

How to Cite

S P Singh , (2025-04-28 16:41:44.482). Interaction Monitoring: A Secure Covid-19 Charting Framework Using the. JANOLI International Journal of Applied Engineering and Management, Volume D0yPfb5bqzwnvXQdjUkv, Issue 1.

Follow Us
Get In Touch

Vitthal Namdev Nagar, Opp Jain Temple Sanganer Sanganer Bazar Jaipur 302029 Rajasthan (India)

mail@janolijournals.org

© JANOLI International Journal. All Rights Reserved.